Voices from the Field: A Qualitative Study of the Challenges and Promising Practices of Rural Public Health in Addressing HIV and Hepatitis C

Abstract

Rural areas of the United States may be vulnerable to an HIV or hepatitis C (HCV) outbreak among persons who inject drugs. We conducted semi-structured interviews with 36 state and local public health professionals from six rural states to gain an understanding of the challenges rural communities face and strategies they are using to prepare for, identify, and respond to HIV and/or HCV outbreaks due to intravenous drug use. Key informants described inadequate funding, insufficient staffing, limited health care infrastructure, and other factors as limiting the public health capacity of rural areas. Promising prevention, surveillance, and treatment strategies in rural areas included the use of mobile treatment units, telemedicine approaches, and community education initiatives to overcome resistance to evidence-based harm reduction programs.

Keywords

Rural communities Hepatitis C HIV Public health Injection drug use

Get full access to this article

View all access options for this article.

References

amfAR, The Foundation for AIDS Research, Opioid & Health Indicators Database. (2019). Syringe Exchange Program Legality. Retrieved August 7, 2020 from https://opioid.amfar.org/indicator/SSP_legality.

amfAR, The Foundation for AIDS Research, Opioid & Health Indicators Database. (2020). Syringe Exchange Programs. Retrieved August 7, 2020 from http://opioid.amfar.org/indicator/num_SSPs.

ASTHO and NORC. (2012). State Public Health Agency Classification: Understanding the Relationship Between State and Local Public Heatlh. https://www.astho.org/Research/Major-Publications/ASTHO-NORC-Governance-Classification-Report/.

Beatty

, Harris

J. K.

, & Barnes

P. A.

(2010). The role of interorganizational partnerships in health services provision among rural, suburban, and urban local health departments. Journal of Rural Health, 26(3), 248–258. https://doi.org/10.1111/j.1748-0361.2010.00285.x.

Bramson

, Des Jarlais

D. C.

, Arasteh

, Nugent

, Guardino

, Feelemyer

, & Hodel

(2015). State laws, syringe exchange. and HIV among persons who inject drugs in the United States: History and effectiveness. Journal of Public Health Policy, 36(212). https://doi.org/10.1057/jphp.2014.54.

Canary

, Hariri

, Campbell

, Young

, Whitcomb

, Kaufman

, & Vellozzi

(2017). Geographic Disparities in Access to Syringe Services Programs Among Young Persons With Hepatitis C Virus Infection in the United States. Clinical Infectious Diseases, 65(3), 514–517. https://doi.org/10.1093/cid/cix333.

CDC. (2018a). HIV Surveillance Report, 2017. Centers for Disease Control and Prevention. https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2017-vol-29.pdf.

CDC. (2018b, March). Managing HIV and hepatitis C outbreaks among people who inject drugs—A guide for state and local health departments. Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Retrieved October 11, 2018 from https://www.cdc.gov/hiv/pdf/programresources/guidance/cluster-outbreak/cdc-hiv-hcv-pwid-guide.pdf.

CDC. (2018c, April 16). Surveillance for Viral Hepatitis - United States, 2016. Centers for Disease Control and Prevention. Retrieved April 8, 2020 from https://www.cdc.gov/hepatitis/statistics/2016surveillance/pdfs/2016HepSurveillanceRpt.pdf.

10.

CDC. (2019). Public Health Emergency Preparedness and Response Capabilities: National Standards for State, Local, Tribal and Territorial Public Health. Centers for Disease Control and Prevention, Center for Preparedness and Response. https://www.cdc.gov/cpr/readiness/00_docs/CDC_PreparednesResponseCapabilities_October2018_Final_508.pdf.

11.

Cloud

D. H.

, Castillo

, Brinkley-Rubinstein

, Dubey

, & Childs

(2018). Syringe Decriminalization Advocacy in Red States: Lessons from the North Carolina Harm Reduction Coalition. Current HIV/AIDS Reports. https://doi.org/10.1007/s11904-018-0397-9.

12.

Davis

M. V.

, Bevc

C. A.

, & Schenck

A. P.

(2014). Declining Trends in local health department preparedness capacities. American Journal of Public Health, 104(11), 2233–2238. https://doi.org/10.2105/AJPH.2014.302159.

13.

Des Jarlais

D. C.

, Nugent

, Solberg

, Feelemyer

, Mermin

, & Holtzman

(2015). Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas - United States, 2013. MMWR: Morbidity and Mortality Weekly Report, 64(48), 1337–1341. https://doi.org/10.15585/mmwr.mm6448a3.

14.

Easterbrook

P. J.

, Roberts

, Sands

, & Peeling

(2017). Diagnosis of viral hepatitis. Current Opinion in HIV and AIDS, 12(3), 302–314. https://doi.org/10.1097/COH.0000000000000370.

15.

Economic Research Service. (2018). State Data. USDA. Retrieved 13 November, 2018 from https://www.ers.usda.gov/data-products/state-fact-sheets/.

16.

Emory University. (2018). AIDSVu. Emory University Rollins School of Public Health. Retrieved June 13, 2019 from https://www.aidsvu.org.

17.

Fraser

M. R.

, Buffington

, Lipson

, & Meit

(2002). Hepatitis C prevention programs: assessment of local health department capacity. Journal of Public Health Management and Practice, 8(2), 46–49.

18.

Gonsalves

G. S.

, & Crawford

F. W.

(2018). Dynamics of the HIV outbreak and response in Scott County, IN, USA, 2011–15: a modelling study. Lancet HIV, 5(10), e569–e577. https://doi.org/10.1016/s2352-3018(18)30176-0.

19.

Henderson

E. R.

, Subramaniam

D. S.

, & Chen

J. J.

(2018). Rural-urban differences in Human Immunodeficiency Virus testing among US adults: findings from the Behavioral Risk Factor Surveillance System. Sexually Transmitted Diseases, 45(12), 808–812. https://doi.org/10.1097/olq.0000000000000888.

20.

Himmelstein

D. U.

, & Woolhandler

(2016). Public Health's Falling Share of US Health Spending. American Journal of Public Health, 106(1), 56–57. https://doi.org/10.2105/ajph.2015.302908.

21.

HIV.gov. (2020). HIV Basics: Data and Trends, U.S. Statistics Fact Facts. Retrieved March 27, 2020 from https://www.hiv.gov/hiv-basics/overview/data-and-trends/statistics.

22.

Kapadia

S. N.

, Johnston

C. D.

, Marks

K. M.

, Schackman

B. R.

, & Martin

E. G.

(2019). Strategies for Improving Hepatitis C Treatment Access in the United States: State Officials Address High Drug Prices, Stigma, and Building Treatment Capacity. Journal of Public Health Management and Practice, 25(3), 245–252. https://doi.org/10.1097/phh.0000000000000829.

23.

Lenardson

, Janis

, Burgess

, Merrill

, Pearson

, Elbaum-Williamson

& Ziller

(2021). Capacity of Rural Counties to Address an HIV or Hepatitis C Outbreak. University of Southern Maine, Maine Rural Health Research Center.

24.

MacMaster

S. A.

(2004). Harm reduction: a new perspective on substance abuse services. Social Work, 49(3), 356–363.

25.

McAllaster

, & Goodrow

(2018). New SASI Analysis: In the Deep South, Significant Percentages of People Most Impacted by HIV Live Outside Large Urban Areas Demonstrating a Need for Increased Federal Resources. Southern HIV/AIDS Strategy Initiative. https://southernaids.files.wordpress.com/2019/01/new-sasi-analysis-the-urban-non-urban-hiv-divide-in-the-deep-south.pdf.

26.

Meit

, Harris

, Bushar

, Piya

, & Molfino

(2008). Rural Public Health Agency Accreditation. National Opinion Research Center at the University of Chicago.

27.

Meit

, Hernandez

, & Kronstadt

(2012). Establishing and Maintaining Rural Public Health Infrastructure. National Opinion Research Center, Walsh Center for Rural Health Analysis.

28.

Murthy

B. P.

, Molinari

N. A. M.

, LeBlanc

T. T.

, Vagi

S. J.

, & Avchen

R. N.

(2017). Progress in Public Health Emergency Preparedness-United States, 2001–2016. American Journal of Public Health, 107(S2), S180–S185. https://doi.org/10.2105/AJPH.2017.304038.

29.

NACCHO. (2016). Public Health Emergency Preparedness Landscape: Findings from the 2015 Preparedness Profile Survey. National Association of County & City Health Officials.

30.

NACCHO. (2017). 2016 National Profile of Local Health Departments. National Association of County & City Health Officials.

31.

NIDA. (2018). Opioid Summaries by State. National Institute on Drug Abuse. Retrieved June 13, 2019 from https://www.drugabuse.gov/drugs-abuse/opioids/opioid-summaries-by-state.

32.

Office of Infectious Disease and HIV/AIDS Policy. (2016). Viral Hepatitis in the United States: Data and Trends. Retrieved March 27, 2020 from https://www.hhs.gov/hepatitis/learn-about-viral-hepatitis/data-and-trends/index.html.

33.

Office of Management and Budget. (2013). Revised Delineations of Metropolitan Statistical Areas, Micropolitan Statistical Areas, and Combined Statistical Areas, and Guidance on Uses of the Delineations of These Areas (OMB Bulletin No. 13–01). https://www.bls.gov/bls/omb-bulletin-13-01-revised-delineations-of-metropolitan-statistical-areas.pdf.

34.

Ohl

M. E.

, & Perencevich

(2011). Frequency of human immunodeficiency virus (HIV) testing in urban vs. rural areas of the United States: results from a nationally-representative sample. BMC Public Health, 11, 681. https://doi.org/10.1186/1471-2458-11-681.

35.

Paquette

C. E.

, & Pollini

R. A.

(2018). Injection drug use, HIV/HCV, and related services in nonurban areas of the United States: A systematic review. Drug and Alcohol Dependence, 188, 239–250. https://doi.org/10.1016/j.drugalcdep.2018.03.049.

36.

Reif

, Golin

C. E.

, & Smith

S. R.

(2005). Barriers to accessing HIV/AIDS care in North Carolina: rural and urban differences. AIDS Care, 17(5), 558–565. https://doi.org/10.1080/09540120412331319750.

37.

Reif

, Pence

B. W.

, Hall

, Hu

, Whetten

, & Wilson

(2015). HIV Diagnoses, Prevalence and Outcomes in Nine Southern States. Journal of Community Health, 40 (4), 642–651. https://doi.org/10.1007/s10900-014-9979-7.

38.

Reif

, Wilson

, & McAllaster

(2017). HIV Stigma Study in the Deep South: Descriptive Findings. Duke University, Southern HIV/AIDS Strategy Initiative (SASI). https://southernaids.files.wordpress.com/2017/08/revised-stigma-report-formatted-in-pdf.pdf.

39.

Schafer

K. R.

, Albrecht

, Dillingham

, Hogg

R. S.

, Jaworsky

, Kasper

, Loutfy

, MacKenzie

L. J.

, McManus

K. A.

, Oursler

K. A. K.

, Rhodes

S. D.

, Samji

, Skinner

, Sun

C. J.

, Weissman

, Ohl

M. E.

, & North Amer Rural H. I. V. Working Group. (2017). The Continuum of HIV Care in Rural Communities in the United States and Canada: What Is Known and Future Research Directions. JAIDS -Journal of Acquired Immune Deficiency Syndromes, 75(1), 35–44. https://doi.org/10.1097/qai.0000000000001329.

40.

Schranz

A. J.

, Barrett

, Hurt

C. B.

, Malvestutto

, & Miller

W. C.

(2018). Challenges Facing a Rural Opioid Epidemic: Treatment and Prevention of HIV and Hepatitis C. Current HIV/AIDS Reports, 15(3), 245–254. https://doi.org/10.1007/s11904-018-0393-0.

41.

Stephens

D. B.

, Young

A. M.

, & Havens

J. R.

(2017). Healthcare contact and treatment uptake following hepatitis C virus screening and counseling among rural Appalachian people who use drugs. International Journal on Drug Policy, 47, 86–94. https://doi.org/10.1016/j.drugpo.2017.05.045.

42.

Suryaprasad

A. G.

, White

J. Z.

, Xu

, Eichler

B.-A.

, Hamilton

, Patel

, Hamdounia

S. B.

, Church

D. R.

, Barton

, Fisher

, Macomber

, Stanley

, Guilfoyle

S. M.

, Sweet

, Liu

, Iqbal

, Tohme

, Sharapov

, Kupronis

B. A.

, Ward

J. W.

, & Holmberg

S. D.

(2014). Emerging Epidemic of Hepatitis C Virus Infections Among Young Nonurban Persons Who Inject Drugs in the United States, 2006–2012. Clinical Infectious Diseases, 59(10), 1411–1419. https://doi.org/10.1093/cid/ciu643.

43.

Trust for America's Health. (2017). A Funding Crisis for Public Health and Safety: State-by-State Public Health Funding and Key Health Facts. Author.

44.

Trust for America's Health. (2020). The Impact of Chronic Underfunding on America's Public Health System: Trends, Risks, and Recommendations, 2020. Author.

45.

Van Handel

M. M.

, Rose

C. E.

, Hallisey

E. J.

, Kolling

J. L.

, Zibbell

J. E.

, Lewis

, Bohm

M. K.

, Jones

C. M.

, Flanagan

B. E.

, Siddiqi

A. E.

, Iqbal

, Dent

A. L.

, Mermin

J. H.

, McCray

, Ward

J. W.

, & Brooks

J. T.

(2016). County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States. Journal of Acquired Immune Deficiency Syndromes, 73(3), 323–331. https://doi.org/10.1097/qai.0000000000001098.

46.

Watson

C. R.

, Watson

, & Sell

T. K.

(2017). Public Health Preparedness Funding: Key Programs and Trends From 2001 to 2017. American Journal of Public Health, 107 (S2), S165–s167. https://doi.org/10.2105/ajph.2017.303963.

47.

Zeremski

, Zibbell

J. E.

, Martinez

A. D.

, Kritz

, Smith

B. D.

, & Talal

A. H.

(2013). Hepatitis C virus control among persons who inject drugs requires overcoming barriers to care. World Journal of Gastroenterology, 19(44), 7846–7851. https://doi.org/10.3748/wjg.v19.i44.7846.

48.

Zibbell

J. E.

, Asher

A. K.

, Patel

R. C.

, Kupronis

, Iqbal

, Ward

J. W.

, & Holtzman

(2018). Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014. American Journal of Public Health, 108(2), 175–181. https://doi.org/10.2105/AJPH.2017.304132.

49.

Zibbell

J. E.

, Hart-Malloy

, Barry

, Fan

, & Flanigan

(2014). Risk factors for HCV infection among young adults in rural New York who inject prescription opioid analgesics. American Journal of Public Health, 104(11), 2226–2232. https://doi.org/10.2105/AJPH.2014.302142.

50.

Zibbell

J. E.

, Iqbal

, Patel

R. C.

, Suryaprasad

, Sanders

K. J.

, Moore-Moravian

, Serrecchia

, Blankenship

, Ward

J. W.

, Holtzman

, & Centers for Disease Control and Prevention. (2015). Increases in hepatitis C virus infection related to injection drug use among persons aged </=30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006–2012. MMWR: Morbidity and Mortality Weekly Report, 64 (17), 453–458.